Navigation Links
New Jersey Hospital Association Presents Awards for Commitment to Healthcare
Date:2/29/2008

PRINCETON, N.J., Feb. 29 /PRNewswire-USNewswire/ -- Several individuals and organizations were honored at the 89th Annual Meeting of the New Jersey Hospital Association (NJHA) today at the Hyatt Regency Princeton.

NJHA's 2008 Distinguished Service award was presented to George F. Lynn, former chief executive officer of AtlantiCare in Egg Harbor Township. Lynn, of Linwood, was honored for his years of service and leadership to AtlantiCare and its patients, as well as his commitment to healthcare far beyond the hospital's walls. A respected leader with an effective voice for hospitals and healthcare issues, Lynn's dedication was also felt nationwide through his service as chairman of the American Hospital Association.

The NJHA Healthcare Professional of the Year award was presented to Carl Marchetti, MD, of Jersey Shore University Medical Center, Meridian Health. For more than 40 years, Dr. Marchetti, of Ocean Township, has dedicated his career to patient care. A highly respected obstetrician and gynecologist, he's welcomed more than 5,000 babies into the world and was the first physician to join the hospital's administration. During his long career at Meridian, he's helped guide and deliver many advanced healthcare services and programs to the residents of Monmouth and Ocean counties.

The NJHA Trustee of the Year award was presented to Miles W. Truesdell Jr., of Stone Harbor, for his dedicated service and leadership to the board of Capital Health System in Trenton. Truesdell was instrumental in the successful merger of Mercer Medical Center and Helene Fuld Medical Center in 1997, and his commitment was essential in transforming the two inner-city hospitals into a high-quality regional resource for patients and physicians.

NJHA also annually recognizes hospitals that demonstrate unique and effective methods of reaching out to better serve the healthcare needs of area residents. The 2008 Health Research and Educational Trust o
'/>"/>

SOURCE New Jersey Hospital Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Video: Circulatory Care of New Jersey
2. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
3. First New York/New Jersey Health Care Report Card Released
4. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
5. New Jersey Nets Shoot Down Staph with High-Tech Defense
6. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
7. New Jersey Entrepreneur Turns a Page for Four National Charities
8. FDA Inspects Hoviones Technology Transfer Center in New Jersey
9. New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos
10. Distinctive Art Auction Supports American Red Cross of Central New Jersey
11. Keisha Orr of Edgewater Park, New Jersey is Named Philadelphias 2007 Local Loser
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... ... 2015 , ... Tyler Boden, Project Developer of Sullivan Solar ... the North American Board of Certified Energy Practitioners (NABCEP®), and is now a ... well established national certification organization for renewable energy professionals. Designation as a NABCEP ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... enrollment on July 2nd creating a buzz of media attention. In an effort ... online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling overwhelmed ...
(Date:7/3/2015)... ... July 03, 2015 , ... Rheumatology ... 2015 Annual Conference , the premiere continuing education and networking event for ... SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts in immunology, ...
(Date:7/3/2015)... ... 03, 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, ... Rhinoplasty Symposium . To be held from March 4th - 6th, the 2016 (a ... Westin Galleria Dallas. , Designed to take participants from the basic training and fundamentals ...
(Date:7/3/2015)... ... 03, 2015 , ... B. E. Smith, the only full-service ... a national chief nursing officer recruitment for Jane Phillips Medical Center ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3
... finds , MONDAY, Dec. 7 (HealthDay News) A new ... in preventing dangerous venous clots as an old standby, warfarin, ... new study finds. , Dabigatran is marketed as Pradax in ... for use in the United States. , The new study, ...
... ... top-of-the-line implementation services to Talyst’s clients in the acute care industry. , ... (PRWEB) December ... the American Society of Health-System Pharmacists in Las Vegas, Talyst announced a partnership ...
... Dec. 7 Hoping to protect their children and grandchildren ... are prepared to make the difficult choices necessary to put ... clear in a report released today by The Concord Coalition ... by a grant from the Peter G. Peterson Foundation, the ...
... , ... 7 Stand Up To Cancer (SU2C) announced today that ... conducted by 13 young scientists. Over a three-year period, each ... part of SU2C,s Innovative Research Grants program, which supports the ...
... , NEW ORLEANS, Dec. 7 Micromet, ... novel, proprietary antibodies for the treatment of cancer, inflammation ... poster(1) with new data from its ongoing phase 1 ... with non-Hodgkin,s lymphoma (NHL) at the 51ST Annual Meeting ...
... , WALTHAM, Mass., Dec. 7 Interleukin Genetics, Inc. ... approval by the State of New York,s Department of Health ... Genetic Test that determines predisposition to severe periodontal disease in ... States in the U.S. However, through its Clinical Laboratory ...
Cached Medicine News:Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:Talyst and RXinnovate Partner on Pharmacy Automation Implementation 2Health News:Concord Coalition Report Shows Eagerness for Reform, Readiness to Make Tough Choices on Fiscal Priorities 2Health News:Concord Coalition Report Shows Eagerness for Reform, Readiness to Make Tough Choices on Fiscal Priorities 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York 2Health News:Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York 3
(Date:7/2/2015)... -- According to a new market research report ... Cord Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, ... by MarketsandMarkets, the global Neuromodulation Market is estimated at $3.65 ... by 2020, at a CAGR of 11.2% during the forecast ... market data T ables and ...
(Date:7/2/2015)... Numotion,s Board of Directors and Mike ... Feitel has joined the Company as Chief Financial ... successful 18 year career at GE serving in executive ... productivity to result in significant industry leading growth and ... Officer for GE Healthcare Global Services, a $5B P&L ...
(Date:7/2/2015)... 25, 2015 ... the addition of the "2015 New ... Challenges, Emerging Technologies, Competitive Landscape" report ... Frontiers in Clinical Chemistry and Immunodiagnostics: Global ... new seven-country strategic analysis of major business ...
Breaking Medicine Technology:Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Numotion Names Tamas Feitel Chief Financial Officer 2New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
... ... ... ... ...
... , ... ... ... ...
Cached Medicine Technology:STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 2STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 3STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 4STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 5STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 6STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 7STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 8STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 9STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 10STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 11STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 12STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 13STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 14STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 15STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 16STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 17Orexigen(R) Therapeutics Schedules March 9, 2010 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2009 2Orexigen(R) Therapeutics Schedules March 9, 2010 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2009 3
... 200 to 350 Liters of pure water, ... Distribution of Purified Water,Millipores compact S.D.S. Storage ... 200 to 350 liters of purified water ... to maintain consistent purity of stored water, ...
... 200 to 350 Liters of pure water, ... Distribution of Purified Water,Millipores compact S.D.S. Storage ... 200 to 350 liters of purified water ... to maintain consistent purity of stored water, ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
Medicine Products: